Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | PALD1 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Pald1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PALD1 mRNA | CTD | PMID:36331819 | PALD1 | Human | 1,1-dichloroethene | increases expression | ISO | Pald1 (Mus musculus) | 6480464 | vinylidene chloride results in increased expression of PALD1 mRNA | CTD | PMID:26682919 | PALD1 | Human | 1,2-dimethylhydrazine | increases expression | ISO | Pald1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of PALD1 mRNA | CTD | PMID:22206623 | PALD1 | Human | 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of PALD1 mRNA | CTD | PMID:22574217 | PALD1 | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of PALD1 mRNA | CTD | PMID:31614463 | PALD1 | Human | 17beta-estradiol | increases expression | ISO | Pald1 (Rattus norvegicus) | 6480464 | Estradiol results in increased expression of PALD1 mRNA | CTD | PMID:32145629 | PALD1 | Human | 17beta-estradiol | decreases expression | ISO | Pald1 (Mus musculus) | 6480464 | Estradiol results in decreased expression of PALD1 mRNA | CTD | PMID:19484750 | PALD1 | Human | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:31675489 | PALD1 | Human | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Pald1 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | PALD1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Pald1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PALD1 mRNA | CTD | PMID:21215274 and PMID:34747641 | PALD1 | Human | 2,4,6-tribromophenol | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:31675489 | PALD1 | Human | 3,3',5,5'-tetrabromobisphenol A | decreases expression | EXP | | 6480464 | tetrabromobisphenol A results in decreased expression of PALD1 protein | CTD | PMID:31675489 | PALD1 | Human | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PALD1 mRNA | CTD | PMID:28628672 | PALD1 | Human | 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid | decreases expression | EXP | | 6480464 | Am 580 results in decreased expression of PALD1 mRNA | CTD | PMID:16982809 | PALD1 | Human | 4-hydroxyphenyl retinamide | increases expression | ISO | Pald1 (Mus musculus) | 6480464 | Fenretinide results in increased expression of PALD1 mRNA | CTD | PMID:28973697 | PALD1 | Human | acetamide | decreases expression | ISO | Pald1 (Rattus norvegicus) | 6480464 | acetamide results in decreased expression of PALD1 mRNA | CTD | PMID:31881176 | PALD1 | Human | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of PALD1 mRNA | CTD | PMID:32763439 | PALD1 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of PALD1 3' UTR and Aflatoxin B1 results in decreased methylation of PALD1 intron | CTD | PMID:30157460 | PALD1 | Human | Aflatoxin B2 alpha | increases methylation | EXP | | 6480464 | aflatoxin B2 results in increased methylation of PALD1 intron | CTD | PMID:30157460 | PALD1 | Human | atrazine | increases expression | EXP | | 6480464 | Atrazine results in increased expression of PALD1 mRNA | CTD | PMID:22378314 | PALD1 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of PALD1 3' UTR more ... | CTD | PMID:27901495 and PMID:30157460 | PALD1 | Human | benzo[e]pyrene | increases methylation | EXP | | 6480464 | benzo(e)pyrene results in increased methylation of PALD1 intron | CTD | PMID:30157460 | PALD1 | Human | bis(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased expression of PALD1 mRNA | CTD | PMID:31163220 | PALD1 | Human | bisphenol A | affects expression | ISO | Pald1 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of PALD1 mRNA | CTD | PMID:25181051 and PMID:32145629 | PALD1 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of PALD1 protein | CTD | PMID:31675489 | PALD1 | Human | bisphenol A | increases expression | ISO | Pald1 (Mus musculus) | 6480464 | bisphenol A results in increased expression of PALD1 mRNA | CTD | PMID:33221593 | PALD1 | Human | bisphenol A | decreases expression | ISO | Pald1 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of PALD1 mRNA | CTD | PMID:30816183 | PALD1 | Human | bisphenol F | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PALD1 mRNA | CTD | PMID:28628672 | PALD1 | Human | buspirone | increases expression | ISO | Pald1 (Rattus norvegicus) | 6480464 | Buspirone results in increased expression of PALD1 mRNA | CTD | PMID:24136188 | PALD1 | Human | carbon nanotube | decreases expression | ISO | Pald1 (Mus musculus) | 6480464 | Nanotubes and Carbon results in decreased expression of PALD1 mRNA | CTD | PMID:25554681 | PALD1 | Human | chlorpyrifos | increases expression | ISO | Pald1 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of PALD1 mRNA | CTD | PMID:37019170 | PALD1 | Human | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of PALD1 mRNA | CTD | PMID:27392435 | PALD1 | Human | CU-O LINKAGE | decreases expression | EXP | | 6480464 | cupric oxide results in decreased expression of PALD1 mRNA | CTD | PMID:22077320 | PALD1 | Human | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PALD1 mRNA | CTD | PMID:28628672 | PALD1 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PALD1 mRNA | CTD | PMID:27188386 | PALD1 | Human | endosulfan | decreases expression | ISO | Pald1 (Rattus norvegicus) | 6480464 | Endosulfan results in decreased expression of PALD1 mRNA | CTD | PMID:29391264 | PALD1 | Human | ethanol | increases expression | ISO | Pald1 (Mus musculus) | 6480464 | Ethanol results in increased expression of PALD1 mRNA | CTD | PMID:30319688 | PALD1 | Human | flutamide | decreases expression | ISO | Pald1 (Rattus norvegicus) | 6480464 | Flutamide results in decreased expression of PALD1 mRNA | CTD | PMID:24136188 | PALD1 | Human | folic acid | decreases expression | ISO | Pald1 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of PALD1 mRNA | CTD | PMID:25629700 | PALD1 | Human | FR900359 | decreases phosphorylation | EXP | | 6480464 | FR900359 results in decreased phosphorylation of PALD1 protein | CTD | PMID:37730182 | PALD1 | Human | furan | decreases expression | ISO | Pald1 (Rattus norvegicus) | 6480464 | furan results in decreased expression of PALD1 mRNA | CTD | PMID:25539665 | PALD1 | Human | gentamycin | decreases expression | ISO | Pald1 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of PALD1 mRNA | CTD | PMID:33387578 | PALD1 | Human | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PALD1 mRNA | CTD | PMID:28628672 | PALD1 | Human | leflunomide | increases expression | ISO | Pald1 (Rattus norvegicus) | 6480464 | leflunomide results in increased expression of PALD1 mRNA | CTD | PMID:24136188 | PALD1 | Human | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | PALD1 | Human | lipopolysaccharide | decreases expression | EXP | | 6480464 | Lipopolysaccharides results in decreased expression of PALD1 mRNA | CTD | PMID:35811015 | PALD1 | Human | methapyrilene | decreases expression | ISO | Pald1 (Rattus norvegicus) | 6480464 | Methapyrilene results in decreased expression of PALD1 mRNA | CTD | PMID:30467583 | PALD1 | Human | methapyrilene | increases methylation | EXP | | 6480464 | Methapyrilene results in increased methylation of PALD1 intron | CTD | PMID:30157460 | PALD1 | Human | methoxychlor | affects methylation | ISO | Pald1 (Rattus norvegicus) | 6480464 | Methoxychlor affects the methylation of PALD1 gene | CTD | PMID:35440735 | PALD1 | Human | N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of PALD1 mRNA | CTD | PMID:24810058 | PALD1 | Human | nefazodone | increases expression | ISO | Pald1 (Rattus norvegicus) | 6480464 | nefazodone results in increased expression of PALD1 mRNA | CTD | PMID:24136188 | PALD1 | Human | nimesulide | increases expression | ISO | Pald1 (Rattus norvegicus) | 6480464 | nimesulide results in increased expression of PALD1 mRNA | CTD | PMID:24136188 | PALD1 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Pald1 (Rattus norvegicus) | 6480464 | AKT activator SC79 inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of PALD1 protein] | CTD | PMID:28439067 | PALD1 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Pald1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PALD1 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of PALD1 mRNA | CTD | PMID:36331819 | PALD1 | Human | perfluorooctane-1-sulfonic acid | decreases expression | ISO | Pald1 (Rattus norvegicus) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of PALD1 protein | CTD | PMID:28439067 | PALD1 | Human | perfluorooctane-1-sulfonic acid | affects localization | ISO | Pald1 (Rattus norvegicus) | 6480464 | perfluorooctane sulfonic acid affects the localization of PALD1 protein | CTD | PMID:28439067 | PALD1 | Human | phenobarbital | decreases expression | ISO | Pald1 (Mus musculus) | 6480464 | Phenobarbital results in decreased expression of PALD1 mRNA | CTD | PMID:19482888 | PALD1 | Human | phenylmercury acetate | decreases expression | EXP | | 6480464 | Phenylmercuric Acetate results in decreased expression of PALD1 mRNA | CTD | PMID:26272509 | PALD1 | Human | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PALD1 mRNA | CTD | PMID:27188386 | PALD1 | Human | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | PALD1 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PALD1 mRNA | CTD | PMID:27188386 | PALD1 | Human | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide analog results in increased expression of PALD1 mRNA and Silicon Dioxide results in increased expression of PALD1 mRNA | CTD | PMID:25895662 and PMID:34973136 | PALD1 | Human | silicon dioxide | decreases expression | ISO | Pald1 (Mus musculus) | 6480464 | Silicon Dioxide results in decreased expression of PALD1 mRNA | CTD | PMID:29203145 | PALD1 | Human | sodium arsenate | increases expression | ISO | Pald1 (Mus musculus) | 6480464 | sodium arsenate results in increased expression of PALD1 mRNA | CTD | PMID:30953684 | PALD1 | Human | succimer | multiple interactions | ISO | Pald1 (Mus musculus) | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PALD1 mRNA | CTD | PMID:21641980 | PALD1 | Human | tetrachloromethane | affects expression | ISO | Pald1 (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of PALD1 mRNA | CTD | PMID:17484886 | PALD1 | Human | tetrachloromethane | multiple interactions | ISO | Pald1 (Mus musculus) | 6480464 | PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of PALD1 mRNA] | CTD | PMID:16006527 | PALD1 | Human | thimerosal | decreases expression | EXP | | 6480464 | Thimerosal results in decreased expression of PALD1 mRNA | CTD | PMID:27188386 | PALD1 | Human | thioacetamide | decreases expression | ISO | Pald1 (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of PALD1 mRNA | CTD | PMID:34492290 | PALD1 | Human | troglitazone | decreases expression | ISO | Pald1 (Mus musculus) | 6480464 | troglitazone results in decreased expression of PALD1 mRNA | CTD | PMID:28973697 | PALD1 | Human | trovafloxacin | decreases expression | ISO | Pald1 (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of PALD1 mRNA | CTD | PMID:35537566 | PALD1 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of PALD1 mRNA | CTD | PMID:25979313 | |